Home / Share Price Target / Concord
Concord Drugs Share Price Target 2024, 2025, 2026 to 2039 With Charts
Concord Drugs Limited | |||
 | Symbol: CONCORD | ||
| Price: ₹35.74 | |||
| Exchange: BSE | |||
| -> | |||
Show Table of Contents
Table of Contents
- 0.1: Concord Drugs Financial Performance
- 0.1.1: Is Concord Drugs A Good Buy For Long Term?
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Concord Drugs Share Price Target For 2024
- 1.1.1: Concord Drugs Share Price Target Table For 2024
- 1.1.2: Summary: Concord Drugs Share Price Prediction For 2024
- 1.2: Concord Drugs Share Price Target For 2025
- 1.2.1: Concord Drugs Share Price Target Table For 2025
- 1.2.2: Summary: Concord Drugs Share Price Prediction For 2025
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Concord Drugs Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 2.2: Concord Drugs Share Price Target Table From 2024, 2025, 2026 to 2039
- 3: Concord Drugs Past Performance
Concord Drugs Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 32.81 Crore | Market valuation of Concord Drugs's shares. |
| Revenue (TTM) | 44.92 Crore | Total revenue generated by Concord Drugs over the past twelve months. |
| Net Income (TTM) | +47.24 Lakh | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 5.55% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 25.97% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | -25.25% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio | 0.49 | Company's total debt divided by total shareholder equity. |
| Total Debt | 16.59 Crore | Sum of Concord Drugs's current & long-term financial obligations. |
Is Concord Drugs A Good Buy For Long Term?
Concord Drugs, a small-cap stock with a market capitalization of ₹30.39 crore, presents a mixed picture for long-term investors. While its 5-year return of 58.84% is encouraging, the significant YTD loss of -39.89% and a substantial debt of ₹16.59 crore (Q1 2024-25) raise concerns. Despite a healthy profit margin of 1.07% (₹47.24 lakh net profit on ₹44.92 crore revenue), the recent revenue decline of -25.25% quarter-over-quarter warrants caution. Therefore, Concord Drugs is currently a not a good buy for long-term investment. Further investigation into the reasons for the revenue drop is recommended before considering any investment.
To predict the Concord Drugs's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Concord Drugs Share Price Target For 2024
The line chart displays the monthly closing prices of Concord Drugs with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Concord Drugs shares in 2024, see the table below.
Concord Drugs Share Price Target Table For 2024
| Concord Drugs's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 37.79 (+5.73%) | Price Action: May 2024 High |
| 2024 Target 2 | 37.39 (+4.61%) | Price Action: 30 Oct 2024 High |
| 2024 Target 1 | 36.98 (+3.46%) | Technical Indicator: MA50 |
| Current Price | 35.74 | Concord Drugs's 1 share price as of Thu 21 Nov 2024 |
| Stop Loss 1 | 36.10 (+1%) | Price Action: Aug 2024 Low |
| Stop Loss 2 | 35.64 (-0.28%) | Price Action: 29 Oct 2024 Low |
| Stop Loss 3 | 35.21 (-1.49%) | Price Action: 18 Oct 2024 Low |
Summary: Concord Drugs Share Price Prediction For 2024
In summary, Concord Drugs has declined by ₹-23.98, recording a notable -40.15% decrease from 1st January 2024 to 21 Nov 2024. Despite the setback, our analysis of Concord Drugs for 2024 predicts an additional rise of 3.46% to 5.73% by the end of 2024 with three potential targets T1: 36.98, T2: 37.39, T3: 37.79. Stop Loss at SL1: 36.10, SL2: 35.64, SL3: 35.21.
Concord Drugs has a 52-week high of ₹61.50, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹30.59, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Concord Drugs.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Concord Drugs Share Price Target For 2025
The line chart displays the monthly closing prices of Concord Drugs with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Concord Drugs shares in 2025, see the table below.
Concord Drugs Share Price Target Table For 2025
| Concord Drugs's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 57.29 (+60.29%) | Price Action: Chart |
| 2025 Target 2 | 56.22 (+57.3%) | Price Action: Chart |
| 2025 Target 1 | 55.66 (+55.73%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 35.74 | Concord Drugs's 1 share price as of Thu 21 Nov 2024 |
| Stop Loss 1 | 31.80 (-11.03%) | Price Action: May 2022 High |
| Stop Loss 2 | 31.48 (-11.92%) | Price Action: Chart |
| Stop Loss 3 | 31.00 (-13.27%) | Price Action: Oct 2017 High |
Summary: Concord Drugs Share Price Prediction For 2025
In summary, Concord Drugs has declined by ₹-23.98, recording a notable -40.15% decrease from 1st January 2024 to 21 Nov 2024. Despite the setback, our analysis of Concord Drugs for 2025 predicts an additional rise of 55.73% to 60.29% by the end of 2025 with three potential targets T1: 55.66, T2: 56.22, T3: 57.29. Stop Loss at SL1: 31.80, SL2: 31.48, SL3: 31.00.
Concord Drugs has a All-Time high of ₹91.25, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹30.59, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Concord Drugs, we have created a specific page for that check here: Concord Drugs Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Concord Drugs Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Concord Drugs share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of -0.72% over the next 15 years.
For complete year by year Concord Drugs long term share price target from 2024, 2025 to 2039 check the below table.
Concord Drugs Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Concord Drugs Target | YoY Change % |
|---|---|---|
| 2024 | ₹35.74 | [Current Price] |
| 2024 | ₹37.28 | 4.3% |
| 2025 | ₹37.61 | 0.91% |
| 2026 | ₹36.69 | -2.48% |
| 2027 | ₹35.43 | -3.44% |
| 2028 | ₹36.29 | 2.42% |
| 2029 | ₹36.4 | 0.3% |
| 2030 | ₹36.72 | 0.9% |
| 2031 | ₹35.81 | -2.51% |
| 2032 | ₹34.58 | -3.44% |
| 2033 | ₹35.4 | 2.4% |
| 2034 | ₹35.51 | 0.28% |
| 2035 | ₹35.83 | 0.9% |
| 2036 | ₹34.92 | -2.54% |
| 2037 | ₹33.72 | -3.44% |
| 2038 | ₹34.53 | 2.4% |
| 2039 | ₹33.68 | -2.47% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Concord Drugs Past Performance
- In 2015, Concord Drugs opening price was ₹25.45
- As of Thu 21 Nov 2024 the price stands at ₹35.74.
- This represents a Compound Annual Growth Rate (CAGR) of 3.45%.
- In 9 years, an investment of 10,000 would have become ₹14,043.22.
As we wrap up, we hope you like our study on Concord Drugs share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
